April 29, 2024
“Controligarchs” reveals the secret attempts by billionaires like George Soros and Warren Buffett to make money off a controversial abortion drug via a shell corporation in the Cayman Islands, as well as the way this pill was brought to market thanks to shadowy deals between the Rockefeller Foundation and President Bill Clinton’s Food and Drug Administration.

The U.S. Supreme Court (SCOTUS) is once again set to make a major abortion ruling ahead of a presidential election. And my new book contains fresh information about the controversial abortion drug facing an ultimate decision from SCOTUS.

Controligarchs: Exposing the Billionaire Class, Their Secret Deals, and the Globalist Plot to Dominate Your Life uncovers never-before-reported details about the elite interests that profit from birth control methods like drugs, contraceptives, and abortions.


This all comes on the heels of the abortion lobby’s victories last Tuesday. In Ohio, abortion rights supporters won a ballot measure, Kentucky’s Democratic governor was reelected on a pro-abortion platform, and a Pennsylvania Supreme Court seat was won by a Democrat after pledging to uphold abortion rights. These pro-abortion victories are spurring attempts for ballot measures in several swing states: Arizona, Florida, Nevada, and Pennsylvania. And abortion is a major moneymaker for the Controligarchs.

The book not only reveals the secret attempts by billionaires such as George Soros and Warren Buffett’s to make huge amounts of money through a controversial abortion drug “RU-486” via a shell corporation in the Cayman Islands, but also how that pill was brought to market thanks to shadowy deals made between the Rockefeller Foundation and President Bill Clinton’s Food and Drug Administration (FDA).

Last November, the Alliance Defending Freedom representing a group of pro-life medical organizations sued the FDA for its Clinton-era approval of the abortion-inducing mifepristone drug (also known as RU-486). In April, a federal district court in Texas ruled against the FDA’s “unlawful approval” of mifepristone.

Billionaire financier George Soros at the World Economic Forum in Davos, Switzerland, on January 23, 2004. (Daniel Acker/Bloomberg via Getty Images)

In September, Biden’s Justice Department and the drug’s manufacturer asked SCOTUS to reverse the lower court’s ruling that restricted access to mifepristone. SCOTUS has not yet determined the final fate of the drug, though abortion advocates, including more than 600 Democratic lawmakers across 49 states, have implored the court to allow the drug to remain available and distributed via organizations like Planned Parenthood.

Against this backdrop, the revelations in Controligarchs about how the abortion-inducing drug was developed, how it came to market, and how it created a secret stream of profits to billionaires such as Soros and Buffett, could not be timelier.

Mifepristone, or RU-486, is an abortifacient (or abortion-inducing) drug with origins dating back to the 1980s. It was brought to America in the 1990s by German pharmaceutical conglomerate Hoechst AG in partnership with the Rockefeller Foundation’s Population Council.

Warren Buffett speaks onstage at the FORTUNE Most Powerful Women Summit on October 16, 2013, in Washington, DC. (Paul Morigi/Getty Images for FORTUNE)

Upon his inauguration in January 1993, President Clinton immediately signed multiple executive orders making abortion access more widely available. One of these orders opened the door for the sale of abortion-inducing drugs like RU-486. The Rockefeller’s Population Council and Hoechst sprang into action and began meeting with Clinton’s FDA in April 1993.

Initially, there were reports that some Hoechst officials were “dismayed” that American pro-life groups were leveling accusations that “Hoechst and [its RU-486 subsidiary] were doing to fetuses what the Nazis had done to the Jews. I.G. Farben, Hoechst’s ancestor company, manufactured cyanide gas for the death camps.”

As it happened, Hoechst was the German successor of Zyklon B manufacturer I.G. Farben, which was known as “the devil’s chemist” due to its important role in Adolf Hitler’s war machine.

Road through the I.G. Farben AG plant from Frankfurt to Hoechst in 1929. (Hans G. Casparius/ullstein bild via Getty Images)

Officials from the I.G. Farben company are seen during their trial for war crimes by the U.S. Military Tribunals in Nuremberg, Germany, on August 14, 1947, following World War II. (AP Photo/Str)

The Jerusalem Post reported that “the Rockefeller Foundation also supported German eugenics, even funded the ‘program that Josef Mengele worked in before he went to Auschwitz.’” In 2021, the Rockefeller Foundation distanced itself from its eugenics history. “The Rockefeller Foundation is currently reckoning with our own history in relation to eugenics,” foundation president Rajiv Shah wrote.

The Spring 1993 meetings with Clinton’s FDA culminated in Hoechst’s decision to donate “its patent rights for RU-486 to the Population Council, with the understanding that the Council would take the steps necessary to bring the drug to market.”

After the Clinton administration signaled approval for RU-486, the Rockefeller Foundation’s Population Council licensed the patent rights to a group called Danco Laboratories. Danco then made alliances with pro-abortion groups such as the National Abortion Federation, Planned Parenthood of America, and the National Abortion and Reproductive Rights Action League.

Controligarchs sifts through a mountain of obscure records and confirms that Danco Laboratories was a for-profit venture, secretly established in the Cayman Islands in 1995. Danco Laboratories’ investors were none other than George Soros, Warren Buffett, and other billionaire elites.

Drug-induced (or chemical) abortions now account for more than half of all abortions in the US. A study cited in one of the Texas court filings under review by SCOTUS concluded that drug-induced abortions—like those using mifepristone—come with a risk of adverse events that is “fourfold higher” than surgical abortions, including much greater risks of “hemorrhaging, incomplete abortion, and unplanned surgical evacuation.”

And 77.1 percent of mifepristone patients reported post-abortion pain compared with 10.5% of surgical patients, the suit alleged. A SCOTUS decision on mifepristone’s fate is expected in the coming months.

Seamus Bruner is the author of Controligarchs: Exposing the Billionaire Class, Their Secret Deals, and the Globalist Plot to Dominate Your Life and the Director of Research at Peter Schweizer’s Government Accountability Institute (GAI).

Follow him @SeamusBruner.